title: [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
authors.forename: L
authors.initials: L
authors.lastname: Lamriben
authors.forename: F
authors.initials: F
authors.lastname: Tiberghien
authors.forename: J L
authors.initials: JL
authors.lastname: Delacour
authors.forename: C
authors.initials: C
authors.lastname: Floriot
authors.forename: G
authors.initials: G
authors.lastname: Wagschal
authors.forename: P
authors.initials: P
authors.lastname: Daoudal
authors.forename: J P
authors.initials: JP
authors.lastname: Ory
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid
vernacular_title: Intérêt de l'orgaran en hémodialyse au cours d'une thrombopénie à l'héparine.